Abstract
Evidence-based statements on port care are a rarity; most recommendations are based on empiricism. The most important measure in port care is compliance with hygiene guidelines. Only suitable special cannulas may be used for puncture. To reduce the risk of thrombosis and infection, blood sampling from the central venous line should be avoided. Ports should be flushed before and after fluid infusion or injection. There is no evidence for the type and amount of flushing solution, but usually only sterile saline is recommended for flushing and saline without added heparin may also be recommended for blocking the port.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bertoglio S, Solari N, Meszaros P, Vassallo F, Bonvento M, Pastorino S, Bruzzi P (2012) Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Cancer Nurs 35:E35–E42
Bischoff SC, Arends J, Dörje F et al (2013a) S3-Leitlinie der Deutschen Gesellschaft für Ernährungsmedizin (DGEM) in Zusammenarbeit mit der GESKES und der AKE. Künstliche Ernährung im ambulanten Bereich. Aktuel Ernahrungsmed 38:e101–e154
Bouza E, Burillo A, Muñoz P (2002) Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 8:265–274
Del Pozo JL, GarcÃa Cenoz M, Hernáez S, MartÃnez A, Serrera A, Aguinaga A, Alonso M, Leiva J (2009) Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis. Int J Antimicrob Agents 34:482–485
Department of Health. Queensland Government (2015) Guideline: totally implantable central venous access ports. www.health.qld.gov.au/__data/assets/pdf_file/0030/444486/icare-port-guideline.pdf
Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut (RKI) (2002) Prävention Gefäßkatheter-assoziierter Infektionen. Bundesgesundheitsbl—Gesundheitsforsch -Gesundheitsschutz 45:907–924
Goossens GA (2015) Flushing and locking of venous catheters: available evidence and evidence deficit. Nurs Res Pract 2015:985686
Goossens GA, Jérôme M, Janssens C, Peetermans WE, Fieuws S, Moons P, Verschakelen J, Peerlinck K, Jacquemin M, Stas M (2013) Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Ann Oncol 24:1892–1899
Kao HF, Chen IC, Hsu C, Chang SY, Chien SF, Chen YC, Hu FC, Yang JC, Cheng AL, Yeh KH (2014) Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers. Support Care Cancer 22:1189–1197
Kefeli U, Dane F, Yumuk PF, Karamanoglu A, Iyikesici S, Basaran G, Turhal NS (2009) Prolonged interval in prophylactic heparin flushing for maintenance of subcutaneous implanted port care in patients with cancer. Eur J Cancer Care (Engl) 18:191–194
Kuo YS, Schwartz B, Santiago J, Anderson PS, Fields AL, Goldberg GL (2005) How often should a port-a-Cath be flushed? Cancer Investig 23:582–585
Kurul S, Saip P, Aydin T (2002) Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol 3:684–692
Liu Y, Zhang AQ, Cao L, Xia HT, Ma JJ (2013) Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One 8:e79417
Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1–45
Odabas H, Ozdemir NY, Ziraman I, Aksoy S, Abali H, Oksuzoglu B, Isik M, Civelek B, Dede D, Zengin N (2014) Effect of port-care frequency on venous port catheter-related complications in cancer patients. Int J Clin Oncol 19:761–766
Pittiruti M, Bertoglio S, Scoppettuolo G et al (2016) Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus. J Vasc Access 17:453–464
Rosenbluth G, Tsang L, Vittinghoff E, Wilson S, Wilson-Ganz J, Auerbach A (2014) Impact of decreased heparin dose for flush-lock of implanted venous access ports in pediatric oncology patients. Pediatr Blood Cancer 61:855–858
Vassallo M, Dunais B, Roger PM (2015) Antimicrobial lock therapy in central-line associated bloodstream infections: a systematic review. Infection 43:389–398
Vescia S, Baumgärtner AK, Jacobs VR, Kiechle-Bahat M, Rody A, Loibl S, Harbeck N (2008) Management of venous port systems in oncology: a review of current evidence. Ann Oncol 19:9–15
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer-Verlag GmbH Germany, part of Springer Nature
About this chapter
Cite this chapter
Grundmann, R.T. (2022). Evidence of Port Care. In: Hennes, R., Müller, G. (eds) Port Care. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-64494-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-64494-2_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-64493-5
Online ISBN: 978-3-662-64494-2
eBook Packages: MedicineMedicine (R0)